5-62306494-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4BP6
The NM_001098511.3(KIF2A):āc.22A>Gā(p.Lys8Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00000072 in 1,389,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001098511.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIF2A | NM_001098511.3 | c.22A>G | p.Lys8Glu | missense_variant | Exon 1 of 21 | ENST00000407818.8 | NP_001091981.1 | |
KIF2A | NM_004520.5 | c.22A>G | p.Lys8Glu | missense_variant | Exon 1 of 20 | NP_004511.2 | ||
KIF2A | NM_001243953.2 | c.22A>G | p.Lys8Glu | missense_variant | Exon 1 of 20 | NP_001230882.1 | ||
KIF2A | NM_001243952.2 | c.-263A>G | 5_prime_UTR_variant | Exon 1 of 21 | NP_001230881.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIF2A | ENST00000407818.8 | c.22A>G | p.Lys8Glu | missense_variant | Exon 1 of 21 | 1 | NM_001098511.3 | ENSP00000385000.3 | ||
ENSG00000288643 | ENST00000509663.2 | n.22A>G | non_coding_transcript_exon_variant | Exon 1 of 6 | 3 | ENSP00000502199.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 7.20e-7 AC: 1AN: 1389744Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 685446
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.22A>G (p.K8E) alteration is located in exon 1 (coding exon 1) of the KIF2A gene. This alteration results from a A to G substitution at nucleotide position 22, causing the lysine (K) at amino acid position 8 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at